Brookfield Business Corp. Signals Tax-Fueled Growth

Brookfield Business Corp. Class A ((TSE:BBUC)) has held its Q1 earnings call. Read on for the main highlights of the call.

Brookfield Business Corp.’s latest earnings call struck an upbeat tone despite some noisy headlines in the numbers. Management leaned heavily on new recurring tax credits, strong asset realizations and resilient same‑store growth to argue that durable cash generation and value creation far outweigh temporary earnings volatility and isolated pockets of portfolio stress.

Clarios tax windfall reshapes cash flow profile

Clarios has already received a $1.0 billion cash tax refund for fiscal 2025, translating to roughly $1.50 per BBUC share and materially lifting free cash flow. Management expects similar annual tax credits through the end of the decade, positioning Clarios as a powerful cash engine that can support deleveraging, reinvestment and potentially higher equity valuations.

Clarios value path implies potential doubling in five years

The company laid out a detailed value-creation bridge for Clarios, which now represents about 30% of NAV, or roughly $15 per share. With current EBITDA around $2.3 billion and a plan to exceed $3 billion within five years, management sees scope for a near doubling of Clarios’ reported value as leverage falls and cash generation approaches $8 billion.

La Trobe sale locks in 3x money and 35% IRR

Brookfield monetized a 27% stake in La Trobe Financial at a $2.0 billion valuation after growing assets under management from $10 billion to $16 billion. The sale delivered about $1.00 per BBUC share, a 35% internal rate of return and a 3x multiple on invested capital in under four years, underscoring the group’s ability to crystallize value.

AI deployment deal with OpenAI adds strategic edge

The firm will lead a $500 million DeployCo investment alongside OpenAI, with BBUC’s share around $150 million via preferred securities. The structure targets high‑teens minimum returns while giving Brookfield’s roughly 300 operating companies early access to advanced AI models and talent, reinforcing both downside protection and strategic upside.

Simplified structure boosts trading liquidity

Following a corporate simplification completed in March, BBUC’s trading volumes are up around 40% versus last year’s averages. Management also expects roughly 5 million shares of incremental demand from index rebalancing, which should further enhance liquidity and broaden the shareholder base.

Strong balance sheet supports capital deployment and buybacks

Pro forma corporate liquidity stood near $2.4 billion at quarter‑end, giving ample flexibility for capital allocation. The company completed its $250 million buyback program and has deployed about $285 million in total repurchases so far, including roughly $65 million during and after the quarter, while keeping an opportunistic stance under the NCIB.

Underlying segments deliver steady same‑store growth

Adjusted EBITDA for the quarter came in at $582 million versus $591 million a year ago, but underlying trends were healthier than the headline suggests. Excluding tax items, acquisitions and disposals, adjusted EBITDA rose about 5% year over year, with the industrial segment up 5.3% to $320 million and same‑store industrial EBITDA growing 7%.

Industrial and business services show broad-based momentum

Within industrial operations, engineered components posted double‑digit same‑store growth, highlighting solid demand and pricing power. Business services also delivered around 7% same‑store growth, reinforcing management’s message that core operating franchises are expanding despite macro and FX noise.

Sagen’s capital-light engine delivers >20% ROE

Sagen has evolved into a high‑return, capital‑light contributor, with return on equity now above 20% compared with low‑double‑digit levels at acquisition. With average new loan credit scores over 760 and about 80% of the book in fixed‑rate mortgages, management believes Sagen can support roughly $400 million of annual distributions over a full cycle.

Adjusted EFO decline reflects prior-period gains

Adjusted EFO slipped to $279 million from $345 million, a roughly 19% year‑over‑year decline that initially raised questions. Management emphasized that the prior period included a $114 million net gain from a disposition, and that excluding such items, the underlying earnings power of the portfolio continues to trend upward.

Rising Sagen loss ratios amid Canadian housing reset

Sagen’s loss ratio increased to about 12%, up from single‑digit levels and above its historical 5% average, as loss‑given‑default rose in 2022–2023 vintages. The move reflects a roughly 20% drop in Canadian home prices since early 2022 and associated reserve strengthening, though management still expects loss ratios to gravitate toward long‑run pricing targets of 15%–20%.

Infrastructure services face tough comparisons

Infrastructure services adjusted EBITDA fell to $90 million from $104 million, a decline of around 13.5% year over year. The shortfall largely reflects the sale of offshore oil shuttle tanker operations and a partial divestment of work access services, which boosted last year’s figures and complicate headline comparisons.

Tax credit timing and select portfolio stress remain watchpoints

While the 2025 Clarios tax credit is in hand, 2024 tax credits are still being processed, leaving some timing uncertainty even as management expresses confidence. Leaders also flagged isolated portfolio stress, including creditor noise at CDK and choppy Brazilian markets, which could weigh on equity values and delay planned monetizations such as the BRK IPO.

Unit fair value markdown modestly dents reported balances

During the quarter, Brookfield reduced the fair value of certain units received in prior partial asset sales by $43 million. The adjustment modestly detracted from reported liquidity and asset balances but was characterized as limited in scope relative to the broader portfolio and liquidity position.

Guidance points to compounding from Clarios and Sagen

Management reaffirmed a multi‑year roadmap anchored by recurring $1.0 billion annual Clarios tax credits and a plan to double Clarios’ value over five years via EBITDA growth, deleveraging and a potential $26 billion equity value. They project Sagen can sustain over 20% ROE and around $400 million in annual distributions, while ongoing buybacks, robust liquidity and the OpenAI DeployCo investment aim to compound value across cycles.

Brookfield Business Corp.’s call framed a portfolio that is absorbing cyclical bumps while steadily building intrinsic value. Recurring tax credits, disciplined monetizations and resilient same‑store growth underpinned a constructive outlook, even as higher loss ratios, segment-specific softness and valuation noise temper near‑term metrics, leaving long‑term shareholders with multiple levers for value creation.